Telehealth ADHD Prescribing: What Prescribers Can Do in Michigan

If you’re a psychiatrist or PMHNP considering telehealth ADHD care, you’re probably asking: Can I legally prescribe Adderall and other stimulants virtually? What about state-specific rules? And is this actually viable as a practice model?

The short answer: Yes, psychiatrists can prescribe ADHD medications via telehealth in 2026 — but the devil’s in the regulatory details, and those details vary dramatically by state and provider type.

Let’s cut through the confusion with what actually matters for your practice.

The Current State of Telehealth ADHD Prescribing (February 2026)

Federal Flexibility Still Applies (For Now)

During COVID-19, the DEA waived the Ryan Haight Act’s requirement for an in-person exam before prescribing Schedule II controlled substances like Adderall via telemedicine. That flexibility has been extended through December 31, 2025 — the third consecutive extension. As of early 2026, providers can still initiate stimulant prescriptions for new ADHD patients entirely through video visits, provided they follow standard of care.

But here’s the catch: this is temporary. Unless Congress passes permanent legislation or the DEA implements new rules (they’ve proposed a ‘special telemedicine registration’ but nothing’s finalized), we could revert to requiring in-person exams for new controlled substance patients sometime in 2026.

What This Means for Your Practice:

• You can currently build a telehealth ADHD practice without worrying about in-person requirements
• Have a contingency plan (partnerships with local clinics, hybrid model) in case regulations change
• Stay subscribed to DEA updates and professional organization alerts

State Laws Can Be More Permissive

Some states have explicitly authorized telehealth prescribing of stimulants for psychiatric conditions, creating a safety net if federal rules tighten. For example:

• Florida explicitly allows Schedule II prescribing via telehealth for ‘psychiatric disorders’ (which includes ADHD)
• Texas permits telehealth controlled substance prescribing for mental health conditions via live video (but not for chronic pain management)
• California and New York default to federal guidelines with no additional state-level telehealth prescribing restrictions for psychiatry

The regulatory landscape is navigable, but you need to know your state’s rules.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

What Psychiatrists Can Do: Clinical Scope in Telehealth ADHD Care

As a physician, you have full prescriptive authority in all 50 states for ADHD medications. Telehealth doesn’t change your scope — only how you deliver care. Here’s what ADHD medication management looks like virtually:

Initial Evaluation

You can conduct comprehensive ADHD assessments via video:

• Clinical interview (symptom history, functional impairment, childhood onset)
• Standardized rating scales (ASRS, ADHD-RS) sent electronically
• Collateral information (teacher reports for kids, partner observations for adults)
• Mental status exam via observation during video call

Physical exam considerations: While you can’t take vitals through a screen, you can:

• Ask patients to self-report blood pressure/heart rate or use home devices
• Coordinate with their PCP for baseline vitals if cardiac concerns exist
• Document that standard monitoring protocols are in place

Most ADHD diagnoses don’t require hands-on examination — the diagnosis is clinical based on history and observation.

Prescribing & Medication Management

You can e-prescribe stimulants and non-stimulants through DEA-compliant platforms (all major telehealth EMRs support EPCS — Electronic Prescribing for Controlled Substances). Key requirements:

• DEA registration in the state where the patient is located (you need state-specific DEA numbers or the DEA 363 ‘Telemedicine Registration’ if treating patients in multiple states from one location)
• State medical license where the patient is located during the visit
• PDMP checks before prescribing (most states mandate checking the Prescription Drug Monitoring Program for controlled substances — some require it every time, others every 90 days)
• E-prescribing (many states now require electronic transmission of controlled substance prescriptions)

Follow-Up Care

Monthly medication checks are standard for stimulants (Schedule II drugs can’t have refills, so patients need monthly prescriptions). Telehealth is ideal for these brief visits:

• 15-20 minute video appointments to assess response, side effects, adherence
• Dose titration based on symptom response
• Billing: Typically 99213 or 99214 E/M codes (Medicare reimburses ~$90-125 per visit)

You can manage the entire ADHD treatment episode virtually — from diagnosis through long-term maintenance — as long as you’re licensed where the patient is located and following controlled substance laws.

The Big Difference: Psychiatrists vs PMHNPs in ADHD Prescribing

This is where things get complicated — and where psychiatrists hold significant leverage.

Psychiatrists (MD/DO): Universal Authority

• Full independent prescribing in all states — no supervision, no quantity limits, no special hoops for Schedule II
• Can practice in any state with appropriate licensure
• Reimbursed at highest rates (Medicare and most private payers pay physicians more than mid-level providers for identical services)

PMHNPs: State-Dependent Authority

Full Practice States (after experience):

• New York: Independent after 3,600 supervised hours (~2 years)
• Illinois: Independent after 4,000 hours + extra training
• California: Transitioning — new ‘104 NP’ category allows independence after 3 years/4,600 hours (plus Schedule II pharmacology course required)

In these states, experienced PMHNPs can manage ADHD patients identically to psychiatrists.

Restricted States — The Big Limitations:

Texas:

• NPs cannot prescribe Schedule II stimulants for outpatient ADHD care at all (state law restricts NP Schedule II prescribing to hospital, hospice, or emergency settings)
• Even with physician collaboration, an NP in Texas cannot write Adderall prescriptions for routine ADHD treatment
• Only psychiatrists can prescribe ADHD stimulants in Texas outpatient settings

Florida:

• NPs require physician supervision (collaborative protocol)
• Generally limited to 7-day supply of Schedule II drugs
• Exception: ‘Psychiatric nurses’ (PMHNPs working under a psychiatrist’s protocol) are exempt from the 7-day limit and can prescribe 30-day supplies of psychotropic controlled substances
• Bottom line: Florida PMHNPs can treat ADHD with stimulants, but they must work with a psychiatrist

Pennsylvania:

• NPs need collaborative agreements
• 72-hour initial limit on Schedule II prescriptions for new patients or new conditions (then physician must be notified)
• Ongoing therapy limited to 30-day supplies
• This creates workflow challenges — often the psychiatrist initiates the stimulant, then NP manages refills

What This Means for Practice Models:

If you’re a psychiatrist, you’re in demand everywhere — especially in restricted states where you’re the only provider type who can independently prescribe ADHD medications. States like Texas and Florida desperately need psychiatrists for this reason.

If you’re a PMHNP, your practice options depend heavily on where you’re licensed:

• In NY/IL/CA (with experience), you can run an independent ADHD practice
• In TX/FL/PA, you’ll need to partner with a psychiatrist or focus on non-stimulant treatment and therapy

Platforms like Klarity navigate this by arranging collaborative agreements in restricted states, but the underlying limitation remains.

Insurance Reimbursement: Can You Actually Make Money Doing This?

Telehealth Payment Parity Is Real

Nearly 48 states now have telehealth parity laws or policies, and Medicare has extended telehealth mental health coverage through at least 2024 (with strong legislative support for permanent extension). For ADHD medication management:

• Medicare reimbursement:

• 99213 (15-min med check): ~$89-95

• 99214 (25-min moderate complexity): ~$125-136

• 90792 (initial psychiatric evaluation): ~$188-202

• Commercial insurance: Usually pays equal to or above Medicare (10-30% higher in many markets)

• Medicaid: Lower rates (~$40-65 for med checks), but still viable with volume

Psychiatrists get paid at physician rates — the highest tier for mental health services. NPs may be reimbursed at 85% of physician rates when billing under their own NPI (though many telehealth practices bill collaboratively to capture full rates).

The Math Works:

If you conduct four 15-minute ADHD med checks per hour via telehealth at $90 each (conservative Medicare rate), that’s $360/hour gross. With commercial payers closer to $110-120 per visit, you’re looking at $440-480/hour.

No office overhead. No commute. No wasted time between patients.

Compare that to the all-in cost of acquiring patients through DIY marketing, and the economics become clear.

The Real Cost of Patient Acquisition: Why DIY Marketing Isn’t the Answer

Here’s where many psychiatrists and PMHNPs get stuck: ‘I’ll just market my own practice. How hard can it be?’

Reality Check: Acquiring a Psychiatric Patient Is Expensive

When you account for all costs, acquiring a qualified ADHD patient through traditional marketing channels typically costs $200-500+ per booked patient:

Google Ads:

• Mental health keywords cost $15-40+ per click
• Conversion rates are terrible — maybe 2-5% of clicks become booked patients
• Realistic cost per booking: $300-500+
• Plus monthly ad spend that doesn’t convert ($1,000-3,000+ in testing and optimization)

SEO (Content Marketing):

• Takes 6-12 months of consistent investment before generating meaningful traffic
• Requires agency fees ($2,000-5,000/month) or significant time investment
• Most solo providers lack the expertise and patience
• Even when it works, you’re competing with national platforms that have bigger budgets

Directory Listings (Psychology Today, Zocdoc):

• Monthly subscription fees ($50-200/month)
• Per-booking fees on top ($35-100+ per patient on Zocdoc)
• You compete with hundreds of other providers on the same page
• Total monthly cost including subscriptions adds up fast

Add in the Hidden Costs:

• Staff time to handle and qualify leads
• No-show rates from cold leads (often 30-40%)
• Failed campaigns and wasted ad spend
• Your own time managing marketing instead of seeing patients

The Bottom Line: Most psychiatrists trying to build an ADHD practice through DIY marketing spend $3,000-5,000/month with uncertain results. It’s gambling on marketing channels with your capital at risk.

Why a Pay-Per-Appointment Model Makes More Sense

This is where platforms like Klarity fundamentally change the economics:

Instead of:

• $3,000-5,000/month in upfront marketing costs
• Months of waiting for SEO to kick in
• Managing ad campaigns, optimizing landing pages, qualifying leads
• Taking all the risk with no guaranteed ROI

You get:

• No upfront marketing spend — zero monthly subscription fees
• Pre-qualified patients already matched to your specialty and availability
• Pay only when a patient books — guaranteed ROI on every dollar spent
• Built-in telehealth infrastructure (no separate platform costs)
• Both insurance and cash-pay patient flow
• You control your schedule completely

The Standard Model: Klarity uses a pay-per-appointment model (similar to Zocdoc) where providers pay a listing fee per new patient lead. The exact fee varies, but the value proposition is simple: you only pay when you see patients.

Why This Works:

Instead of spending thousands hoping to acquire patients, you pay a predictable amount per booked appointment — and you know that patient is already qualified and ready for care. No wasted ad spend. No months of waiting. Just patients who need what you offer.

For a psychiatrist in a restricted state where you’re the only provider who can prescribe stimulants, the demand is there. For an experienced PMHNP in a full-practice state, same story. The platform removes the acquisition risk entirely.

State-by-State Considerations: Where Can You Practice ADHD Telehealth?

California

• Psychiatrists: Full authority, no state telehealth restrictions for ADHD meds
• PMHNPs: Transitioning to independence (need 3 years experience for ‘104 NP’ status; must complete Schedule II pharmacology course)
• Market: Huge demand, competitive in metro areas, severe shortages in rural/Central Valley
• Reimbursement: Strong (high commercial rates due to cost of living)

Texas

• Psychiatrists: Critical shortage (~1:9,000 ratio) — extremely high demand. Can prescribe stimulants via video (must use live video, not audio-only)
• PMHNPs: Cannot prescribe outpatient Schedule II stimulants at all; need MD partner for ADHD medication management
• Market: Massive unmet need, especially rural. Telehealth essential.
• Key consideration: State scrutinizes telehealth prescribing due to past abuses; practice conservatively

Florida

• Psychiatrists: State explicitly allows tele-prescribing of stimulants for ‘psychiatric disorders’ — very permissive
• PMHNPs: Need psychiatrist collaboration; exempt from 7-day Schedule II limit if working as ‘psychiatric nurse’ under MD protocol
• Market: High demand, growing population, low psychiatrist supply (~1:8,500)
• Reimbursement: Moderate rates; parity enforced

New York

• Psychiatrists: Full authority; must check PDMP every time before prescribing
• PMHNPs: Independent after 3,600 hours — no restrictions on stimulants once experienced
• Market: Best psychiatrist ratio in nation (~1:2,900), but rural upstate has gaps. Strong telehealth adoption.
• Requirement: Mandatory e-prescribing; PDMP checks strictly enforced

Pennsylvania

• Psychiatrists: No restrictions
• PMHNPs: Collaborative agreement required; 72-hour initial limit on Schedule IIs (physician must be involved early)
• Market: Moderate supply in cities, shortages in rural areas
• Workflow consideration: NP/MD teams need coordination for initial stimulant prescriptions

Illinois

• Psychiatrists: Full authority
• PMHNPs: Can obtain Full Practice Authority after 4,000 hours + training (increasingly common by 2026)
• Market: Good supply in Chicago, shortages downstate. Strong telehealth support.
• Reimbursement: Parity enforced; Medicaid covers telehealth well

Compliance Essentials: How to Prescribe ADHD Meds Safely via Telehealth

Given increased scrutiny (some telehealth platforms were investigated for inappropriate stimulant prescribing), adherence to best practices isn’t optional:

Documentation Standards

• Thorough diagnostic justification: Document DSM-5 criteria, functional impairment, childhood history
• Informed consent: Cover risks of stimulant therapy, alternatives considered
• Standard of care: Your telehealth evaluation must be as comprehensive as in-person

PDMP Checks

• Check your state’s Prescription Drug Monitoring Program before prescribing
• Some states (NY, CA) mandate checking every time for controlled substances
• Document that you reviewed PDMP and found no red flags

Prescription Monitoring

• Schedule monthly follow-ups (stimulants typically need 30-day scripts with no refills)
• Monitor vitals (even if self-reported), side effects, adherence
• Document therapeutic response and ongoing medical necessity

Avoid Red Flags

• Don’t prescribe to patients you can’t verify (confirm identity, location)
• Be wary of patients requesting specific brands/doses upfront
• Consider urine drug screens if any concerns about misuse
• Coordinate with primary care providers when possible

State-Specific Requirements

• Texas: Must use live video (not audio-only) for controlled substances
• Florida: Document that prescribing is for a psychiatric disorder
• Pennsylvania: Be aware of 72-hour NP limits if working with NPs
• All states: Maintain proper licensure and DEA registration where patient is located

The Bottom Line: Should You Build a Telehealth ADHD Practice?

The opportunity is real:

1. Massive demand: Adult ADHD diagnoses surged during COVID and haven’t slowed down. Ongoing medication shortages reflect overwhelming demand.

2. Regulatory support (for now): Federal telehealth flexibility continues through at least 2025, and many states have created additional safeguards. Payment parity is essentially universal.

3. Economic viability: Reimbursement for telehealth ADHD care equals in-person rates. With no office overhead and efficient scheduling, net income can be higher than traditional practice.

4. Workforce shortages create leverage: States like Texas, Florida, and rural areas everywhere desperately need psychiatrists who can prescribe ADHD medications. If you have those credentials, you’re in demand.

The challenges are navigable:

• State-by-state licensing: You need to be licensed in every state where you treat patients (though interstate compacts are helping)
• Regulatory uncertainty: Federal teleprescribing rules could change in 2026 (though permanent solutions seem likely given bipartisan support)
• Scope restrictions for NPs: If you’re a PMHNP, your ability to prescribe depends entirely on your state

The wrong approach is expensive:

Trying to build this practice through DIY marketing means spending thousands per month with no guaranteed results. You’re competing with national platforms that have dedicated marketing teams and massive budgets.

The right approach is strategic:

Join a platform that already has patient flow, handles all acquisition costs, and provides infrastructure. You pay only when you see patients — guaranteed ROI, no risk, and you can start seeing patients immediately rather than waiting months for SEO or ad campaigns to work.

For psychiatrists, especially in restricted-practice states, you’re uniquely positioned. For experienced PMHNPs in full-practice states, same opportunity. For newer PMHNPs or those in restricted states, partnership models (which platforms like Klarity facilitate) let you participate in this growing market.

The demand isn’t going away. The question is whether you want to spend your time and money gambling on marketing channels, or seeing patients and getting paid for it.

Frequently Asked Questions

Can psychiatrists prescribe ADHD medications via telehealth in 2026?

Yes. Psychiatrists can prescribe stimulants (Adderall, Ritalin, Vyvanse) and non-stimulants through telehealth as of February 2026 under extended federal rules. You need proper state licensure, DEA registration, and must follow PDMP and e-prescribing requirements. This flexibility currently extends through December 31, 2025, with potential for permanent legislation.

Do I need to see ADHD patients in-person before prescribing stimulants?

Not currently. The Ryan Haight Act’s in-person requirement has been waived through end of 2025 for telemedicine prescribing of controlled substances. Some states (like Florida) have created explicit exceptions for psychiatric prescribing via telehealth. If federal rules change in 2026, you may need contingency plans for initial in-person visits, but as of now, you can conduct the entire treatment episode virtually.

Can PMHNPs prescribe Adderall through telehealth?

It depends on the state. PMHNPs in full-practice authority states (New York after 3,600 hours, Illinois after 4,000 hours, California after 4,600 hours) can prescribe stimulants independently. In restricted states like Texas, NPs cannot prescribe Schedule II stimulants for outpatient ADHD at all. In Florida and Pennsylvania, NPs need physician collaboration and face additional limitations (7-day limits in FL with psych nurse exception; 72-hour initial limits in PA).

What does telehealth ADHD care pay?

Medicare reimburses ~$89-95 for a 15-minute medication management visit (99213) and ~$125-136 for a 25-minute visit (99214). Initial evaluations (90792) pay ~$188-202. Commercial insurance typically pays equal or higher (10-30% more). Medicaid pays less (~$40-65) but is still viable. Telehealth payment parity is enforced in nearly all states, meaning virtual visits pay the same as in-person.

How much does it cost to acquire an ADHD patient through marketing?

Realistically, $200-500+ per booked patient when you account for all costs. Google Ads for mental health keywords run $15-40+ per click with low conversion rates. SEO takes 6-12 months and $2,000-5,000/month in agency fees. Directories charge monthly subscriptions plus per-booking fees. Most providers spend $3,000-5,000/month on marketing with uncertain results — that’s why pay-per-appointment models where you only pay when patients book make more financial sense.

Do I need separate licenses for each state I practice in via telehealth?

Yes. You must be licensed in the state where the patient is physically located during the visit. This applies to both physicians and NPs. Some states participate in interstate licensure compacts (the Interstate Medical Licensure Compact for physicians makes getting multiple state licenses easier), but you still need active licensure in each state. DEA registration follows the same rule — you need DEA authority in each state where you prescribe controlled substances to patients.

What are the biggest compliance risks in telehealth ADHD prescribing?

Key risks include: (1) Prescribing without adequate evaluation (telehealth must meet the same standard of care as in-person), (2) Failing to check PDMP databases as required by state law, (3) Not maintaining proper licensure in the patient’s state, (4) Using audio-only calls where state law requires video for controlled substances (e.g., Texas), and (5) Inadequate documentation of medical necessity. Following established ADHD diagnostic criteria, scheduling regular follow-ups, and coordinating with PCPs when appropriate are your best protections.

Which states are best for building a telehealth ADHD practice?

States with severe psychiatrist shortages and permissive telehealth laws offer the most opportunity: Texas and Florida have high demand (~1:9,000 psychiatrist ratios) and explicitly allow telehealth stimulant prescribing for psychiatry. New York and Illinois have strong telehealth infrastructure and eventual NP independence. California offers a huge market but is competitive in metro areas (rural Central Valley has gaps). For psychiatrists, restricted-practice states (TX, FL, PA) actually offer leverage because only MDs can prescribe ADHD stimulants there. For PMHNPs, full-practice states (NY, IL, emerging CA) offer more autonomy.

Ready to Start Seeing ADHD Patients Without the Marketing Gamble?

Instead of spending thousands per month hoping to acquire patients through DIY marketing, join a platform that already has qualified patient flow and handles all the acquisition risk for you.

With Klarity Health:

• Start seeing pre-qualified ADHD patients immediately
• Pay only when patients book (no upfront marketing costs)
• Practice in multiple states with full compliance support
• Built-in telehealth platform and billing infrastructure
• Both insurance and cash-pay patient options

Whether you’re a psychiatrist with full prescribing authority or an experienced PMHNP in a full-practice state, the demand is there. The question is whether you want to spend your time marketing or treating patients.

[Explore Klarity’s Provider Network →]

Sources and Verification

The information in this article is based on current federal and state regulations as of February 2026. All regulatory and scope-of-practice statements have been verified against official sources including state statutes, medical board guidance, and federal agency announcements.

Primary Sources:

1. DEA Controlled Substance Telehealth Extensions

• Axios, ‘COVID-era telehealth prescribing extended again,’ November 18, 2024 (www.axios.com)
• Axios, ‘Telehealth prescribing mess could reach Congress,’ September 18, 2024 (www.axios.com)

1. State Telehealth Laws

• Florida Statutes §456.47 (Telehealth provisions), 2023 edition (www.flsenate.gov)
• Center for Connected Health Policy, ‘Texas State Telehealth Laws,’ updated January 19, 2026 (www.cchpca.org)

1. NP Scope of Practice & Prescribing Authority

• RxAgent, ‘NP Prescriptive Authority by State (2026 Guide),’ updated December 28, 2025 (rxagent.co)
• Florida Statutes §464.012 (APRN prescribing regulations) (www.leg.state.fl.us)
• Texas SB 2527 Bill Analysis, 88th Legislature, April 2023 (capitol.texas.gov)

1. Provider Shortage Data

• Healing Psychiatry Florida, ‘Psychiatrist Shortage by State – 2026 Report,’ January 15, 2026 (www.healingpsychiatryflorida.com)
• Texas Tribune, ‘Texas’ shortage of mental health care professionals is getting worse,’ February 21, 2023

1. ADHD Treatment Trends & Medication Shortages

• Associated Press, ‘More adults sought help for ADHD during pandemic,’ January 10, 2024 (apnews.com)
• Axios Vitals, ‘DEA ramps up production of ADHD meds,’ September 5, 2024 (www.axios.com)

1. Reimbursement Data

• Therathink, ‘Insurance Reimbursement Rates for Psychiatrists [2026],’ updated 2026 (therathink.com)
• BehaveHealth, ‘Mental Health Reimbursement Trends – Telehealth Parity 2026,’ 2024 (behavehealth.com)

Verification Notes:
All federal regulatory information (DEA waivers, Ryan Haight Act) was verified against official federal sources and reputable news outlets covering healthcare policy. State-specific prescribing laws were checked against official state statutes or state medical/nursing board websites. Workforce shortage data comes from healthcare workforce databases and state reports. Reimbursement figures reflect 2024-2025 Medicare fee schedules and industry surveys. All sources were accessed and verified in February 2026.

Regulatory Disclaimer:
Telehealth and controlled substance prescribing laws are subject to change. Providers should verify current regulations in their state(s) of practice and consult with legal counsel or professional organizations when establishing telehealth practices. This article provides general information and should not be construed as legal advice.

Source:

• https://www.axios.com/2024/09/18/telehealth-services-controlled-substances-congress#:~:text=Why%20it%20matters%3A%20Pandemic,end%20of%20this%20year%20after
• https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall#:~:text=The%20Drug%20Enforcement%20Administration%20and,the%20third%20temporary%20extension%20of
• https://www.flsenate.gov/Laws/Statutes/2023/456.47#:~:text=,is%20prescribed%20for%20the%20following
• https://www.flsenate.gov/Laws/Statutes/2023/456.47#:~:text=1,disorder
• https://rxagent.co/blog/np-prescribing-authority#:~:text=OK%20%20,day%20%28ongoing%29%20%5B3
• https://rxagent.co/blog/np-prescribing-authority#:~:text=TN%20%20,NP%3A%20Independent%20%5B3
• https://rxagent.co/blog/np-prescribing-authority#:~:text=match%20at%20L210%20NY%20,terminal%20illness%2C%20MD%20initiation
• https://rxagent.co/blog/np-prescribing-authority#:~:text=ID%20%20,3
• https://rxagent.co/blog/np-prescribing-authority#:~:text=FL%20%20,NP%3A%20Independent%20%5B3
• https://www.leg.state.fl.us/STATUTeS/index.cfm?Appmode=DisplayStatute&Search_String=&URL=0400-0499%2F0464%2FSections%2F0464.012.html#:~:text=also%20limit%20the%20prescribing%20of,shall%20adopt%20by%20rule%20the